bioMérieux S.A. (BMXMF)
USD 103.09
(0.0%)
USD 103.09
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.67 Billion EUR | 2.39% |
| 2022 | 3.58 Billion EUR | 6.3% |
| 2021 | 3.37 Billion EUR | 8.28% |
| 2020 | 3.11 Billion EUR | 16.57% |
| 2019 | 2.67 Billion EUR | 10.47% |
| 2018 | 2.42 Billion EUR | 5.82% |
| 2017 | 2.28 Billion EUR | 8.8% |
| 2016 | 2.1 Billion EUR | 7.05% |
| 2015 | 1.96 Billion EUR | 15.67% |
| 2014 | 1.69 Billion EUR | 6.96% |
| 2013 | 1.58 Billion EUR | 1.15% |
| 2012 | 1.56 Billion EUR | 9.99% |
| 2011 | 1.42 Billion EUR | 5.17% |
| 2010 | 1.35 Billion EUR | 10.92% |
| 2009 | 1.22 Billion EUR | 10.17% |
| 2008 | 1.11 Billion EUR | 4.49% |
| 2007 | 1.06 Billion EUR | 2.5% |
| 2006 | 1.03 Billion EUR | 4.36% |
| 2005 | 993.6 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.9 Billion EUR | -0.14% |
| 2023 Q4 | 1.9 Billion EUR | 7.6% |
| 2023 FY | 3.67 Billion EUR | 2.39% |
| 2023 Q2 | 1.77 Billion EUR | -8.34% |
| 2022 FY | 3.58 Billion EUR | 6.3% |
| 2022 Q2 | 1.65 Billion EUR | -7.99% |
| 2022 Q4 | 1.93 Billion EUR | 16.47% |
| 2021 Q4 | 1.8 Billion EUR | 14.47% |
| 2021 FY | 3.37 Billion EUR | 8.28% |
| 2021 Q2 | 1.57 Billion EUR | -4.13% |
| 2020 Q4 | 1.64 Billion EUR | 11.23% |
| 2020 FY | 3.11 Billion EUR | 16.57% |
| 2020 Q2 | 1.47 Billion EUR | 5.47% |
| 2019 Q2 | 1.27 Billion EUR | 1.84% |
| 2019 Q4 | 1.39 Billion EUR | 9.77% |
| 2019 FY | 2.67 Billion EUR | 10.47% |
| 2018 Q2 | 1.16 Billion EUR | 1.33% |
| 2018 FY | 2.42 Billion EUR | 5.82% |
| 2018 Q4 | 1.25 Billion EUR | 7.09% |
| 2017 Q4 | 1.15 Billion EUR | 1.73% |
| 2017 FY | 2.28 Billion EUR | 8.8% |
| 2017 Q2 | 1.13 Billion EUR | 2.89% |
| 2016 Q4 | 1.1 Billion EUR | 10.15% |
| 2016 FY | 2.1 Billion EUR | 7.05% |
| 2016 Q2 | 1 Billion EUR | -2.97% |
| 2015 FY | 1.96 Billion EUR | 15.67% |
| 2015 Q4 | 1.03 Billion EUR | 10.52% |
| 2015 Q2 | 933.2 Million EUR | 1.69% |
| 2014 Q2 | 780.7 Million EUR | -6.36% |
| 2014 FY | 1.69 Billion EUR | 6.96% |
| 2014 Q4 | 917.7 Million EUR | 17.55% |
| 2013 Q4 | 833.7 Million EUR | 10.54% |
| 2013 FY | 1.58 Billion EUR | 1.15% |
| 2013 Q2 | 754.2 Million EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 FY | 1.56 Billion EUR | 9.99% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q4 | - EUR | 0.0% |
| 2011 FY | 1.42 Billion EUR | 5.17% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 FY | 1.35 Billion EUR | 10.92% |
| 2010 Q4 | - EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2009 FY | 1.22 Billion EUR | 10.17% |
| 2008 FY | 1.11 Billion EUR | 4.49% |
| 2007 FY | 1.06 Billion EUR | 2.5% |
| 2006 FY | 1.03 Billion EUR | 4.36% |
| 2005 FY | 993.6 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -402386.309% |
| Arrayit Corporation | 4.37 Million USD | -83849.01% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | -14111.076% |
| Bioqual, Inc. | 58.59 Million USD | -6171.788% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | -23923.928% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 50.235% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | -57621.851% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -349342.273% |
| Interpace Biosciences, Inc. | 40.21 Million USD | -9037.862% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -821063.846% |
| InVitro International | 792.62 Thousand USD | -463509.663% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | -32913.206% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | -50766.349% |
| NovelStem International Corp. | 12 Thousand USD | -30622400.0% |
| Optigenex Inc. | 465.97 Thousand USD | -788513.001% |
| PharmChem, Inc. | 6.01 Million USD | -61018.658% |
| Proteome Sciences plc | 6.4 Million USD | -57311.41% |
| Response Genetics, Inc | 18.04 Million USD | -20269.734% |
| Rennova Health, Inc. | 13.03 Million USD | -28088.49% |
| RushNet, Inc. | 1.78 Million USD | -205433.928% |
| ScreenPro Security Inc. | 1.91 Million USD | -191880.264% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | -96728.1% |
| Todos Medical Ltd. | 7.69 Million USD | -47654.386% |